JP2023541444A5 - - Google Patents

Info

Publication number
JP2023541444A5
JP2023541444A5 JP2023516690A JP2023516690A JP2023541444A5 JP 2023541444 A5 JP2023541444 A5 JP 2023541444A5 JP 2023516690 A JP2023516690 A JP 2023516690A JP 2023516690 A JP2023516690 A JP 2023516690A JP 2023541444 A5 JP2023541444 A5 JP 2023541444A5
Authority
JP
Japan
Prior art keywords
promoter
nucleotide sequence
nucleic acid
sequence shown
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023516690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023541444A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/050461 external-priority patent/WO2022060841A2/en
Publication of JP2023541444A publication Critical patent/JP2023541444A/ja
Publication of JP2023541444A5 publication Critical patent/JP2023541444A5/ja
Pending legal-status Critical Current

Links

JP2023516690A 2020-09-15 2021-09-15 筋ジストロフィー患者における多様なdmd変異の補正のためのaav媒介性の相同性非依存的標的化組み込み遺伝子編集 Pending JP2023541444A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063078428P 2020-09-15 2020-09-15
US63/078,428 2020-09-15
US202163180232P 2021-04-27 2021-04-27
US63/180,232 2021-04-27
PCT/US2021/050461 WO2022060841A2 (en) 2020-09-15 2021-09-15 Aav-mediated homology-independent targeted integration gene editing for correction of diverse dmd mutations in patients with muscular dystrophy

Publications (2)

Publication Number Publication Date
JP2023541444A JP2023541444A (ja) 2023-10-02
JP2023541444A5 true JP2023541444A5 (cg-RX-API-DMAC7.html) 2024-09-20

Family

ID=78086092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516690A Pending JP2023541444A (ja) 2020-09-15 2021-09-15 筋ジストロフィー患者における多様なdmd変異の補正のためのaav媒介性の相同性非依存的標的化組み込み遺伝子編集

Country Status (6)

Country Link
US (1) US20230357795A1 (cg-RX-API-DMAC7.html)
EP (1) EP4214317A2 (cg-RX-API-DMAC7.html)
JP (1) JP2023541444A (cg-RX-API-DMAC7.html)
AU (1) AU2021345112A1 (cg-RX-API-DMAC7.html)
CA (1) CA3195233A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022060841A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023240157A2 (en) * 2022-06-08 2023-12-14 Scribe Therapeutics Inc. Compositions and methods for the targeting of dmd
CN115806989B (zh) * 2022-11-25 2023-08-08 昆明理工大学 针对DMD基因5号外显子突变的sgRNA及载体和应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
EP0733103B1 (en) 1993-11-09 2004-03-03 Targeted Genetics Corporation Generation of high titers of recombinant aav vectors
DE69433922T2 (de) 1993-11-09 2005-07-28 Medical College Of Ohio, Toledo Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren
US5658785A (en) 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
US5856152A (en) 1994-10-28 1999-01-05 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV vector and methods of use therefor
WO1996017947A1 (en) 1994-12-06 1996-06-13 Targeted Genetics Corporation Packaging cell lines for generation of high titers of recombinant aav vectors
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
JPH11511326A (ja) 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびaavの精製
JPH11514853A (ja) 1995-09-08 1999-12-21 ジエンザイム コーポレイション 遺伝子治療のための改良されたaavベクター
US5910434A (en) 1995-12-15 1999-06-08 Systemix, Inc. Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
EP1696036B1 (en) 1996-09-06 2010-04-21 The Trustees of The University of Pennsylvania Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
CA2995542A1 (en) 1997-09-05 1999-03-11 Genzyme Corporation Methods for generating high titer helper-free preparations of recombinant aav vectors
US6258595B1 (en) 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
JP2004514407A (ja) 2000-04-28 2004-05-20 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター
WO2002053703A2 (en) 2001-01-05 2002-07-11 Children's Hospital, Inc. Aav2 vectors and methods
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
FR2874384B1 (fr) 2004-08-17 2010-07-30 Genethon Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
ES2566553T3 (es) 2010-03-17 2016-04-13 Association Institut De Myologie ARNnp U7 modificados para el tratamiento de las enfermedades neuromusculares
CA2842798C (en) 2011-07-25 2021-02-23 Nationwide Children's Hospital, Inc. Recombinant virus products and methods for inhibition of expression of dux4
DE102012007232B4 (de) 2012-04-07 2014-03-13 Susanne Weller Verfahren zur Herstellung von rotierenden elektrischen Maschinen
EP3004339B1 (en) 2013-05-29 2021-07-07 Cellectis New compact scaffold of cas9 in the type ii crispr system
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
JP2015092462A (ja) 2013-09-30 2015-05-14 Tdk株式会社 正極及びそれを用いたリチウムイオン二次電池
WO2015141521A1 (ja) 2014-03-21 2015-09-24 株式会社日立国際電気 基板処理装置、半導体装置の製造方法及び記録媒体
JP6197169B2 (ja) 2014-09-29 2017-09-20 東芝メモリ株式会社 半導体装置の製造方法
WO2016112242A1 (en) 2015-01-08 2016-07-14 President And Fellows Of Harvard College Split cas9 proteins
EP4279084B1 (en) * 2015-10-28 2025-06-11 Vertex Pharmaceuticals Inc. Materials and methods for treatment of duchenne muscular dystrophy
WO2017193029A2 (en) 2016-05-05 2017-11-09 Duke University Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy
WO2017197238A1 (en) 2016-05-12 2017-11-16 President And Fellows Of Harvard College Aav split cas9 genome editing and transcriptional regulation
CA3030587A1 (en) * 2016-07-15 2018-01-18 Salk Institute For Biological Studies Methods and compositions for genome editing in non-dividing cells
EP3749768A1 (en) * 2018-02-05 2020-12-16 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of hemoglobinopathies
TW202100748A (zh) * 2019-04-14 2021-01-01 美國公爵大學 恢復肌縮蛋白功能之基於crispr/cas之基因組編輯組合物
JP2023507174A (ja) * 2019-12-16 2023-02-21 プレジデント アンド フェローズ オブ ハーバード カレッジ Dmd変異の修正のための方法及び組成物
JP2023522788A (ja) * 2020-04-27 2023-05-31 デューク ユニバーシティ 標的化されたゲノム組込みによってデュシェンヌ型筋ジストロフィーを矯正するためのcrispr/cas9療法

Similar Documents

Publication Publication Date Title
JP2020019772A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
JP2021106619A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2023518541A5 (cg-RX-API-DMAC7.html)
JP2020522269A5 (cg-RX-API-DMAC7.html)
JP2021512649A5 (cg-RX-API-DMAC7.html)
IL292999A (en) Compositions and methods of treating amyotrophic lateral sclerosis (als)
JP2022535749A5 (cg-RX-API-DMAC7.html)
JP2017535266A5 (cg-RX-API-DMAC7.html)
JP2017510298A5 (cg-RX-API-DMAC7.html)
RU2018140499A (ru) Способы и композиции для лечения хореи гентингтона
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
US20170067028A1 (en) Radiolabeling of adeno associated virus
JP2021522836A5 (cg-RX-API-DMAC7.html)
US20220380798A1 (en) AAV Expression Cassette and AAV Vectors Comprising the Same
JP2020519284A5 (cg-RX-API-DMAC7.html)
JP2021534814A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2024508696A5 (cg-RX-API-DMAC7.html)
JP2023524024A5 (cg-RX-API-DMAC7.html)
JP2023553005A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
JP2021534794A5 (cg-RX-API-DMAC7.html)